Search Results 611-620 of 4606 for Diffuse
PET-CT and targeted invasive tissue biopsies are crucial in patients with nonclassic clinical presentations such as noncalcified, diffuse and bilateral ...
... Diffuse glioma. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Research. Malignant glioma cells Enlarge image. Close ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non ...
... Diffuse glioma, Pilocytic astrocytoma, Diffuse midline glioma. Show more areas of focus for Terry C. Burns, M.D., Ph.D. Rich W. Byrne ...
, Glioma, Pediatric brain tumor, Embryonal tumor, Diffuse midline glioma, Atypical teratoid rhabdoid tumor, Diffuse glioma. Show more areas of focus for ...
... diffuse gliomas at first relapse (Phase I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with ...
The purpose of this study is to enroll approximately 235 treatment-naïve subjects with high-risk Diffuse Large B-Cell Lymphoma (DLBCL). Subjects will be ...
... Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of therapy ...
... diffuse large B-cell lymphoma (DLBCL) and Grade 3 follicular lymphoma (FL3). Additionally, the pharmacokinetic profile and antitumor activity of SGN-CD19B ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.